Screener
Vertex Pharmaceuticals VRTX Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Vertex Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Vertex Pharmaceuticals’s 8-K, filed August 3, 2026. Open the filing →
- Filed
- Aug 3, 2026, 4:09 PM EDT
- Accession
- 0000875320-26-000256
FAQ
- What is Vertex Pharmaceuticals's gross margin?
- Vertex Pharmaceuticals (VRTX) reported gross margin of 86% in Q2 2026.
- How has Vertex Pharmaceuticals's gross margin changed year-over-year?
- Vertex Pharmaceuticals's gross margin decreased by 0.1% year-over-year, from 86.1% to 86%.
- What is the long-term trend for Vertex Pharmaceuticals's gross margin?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's gross margin has grown at a -0.4% compound annual growth rate (CAGR), from 88.1% to 86.2%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Vertex Pharmaceuticals's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude